Intravenously Transplanted Human Multilineage-Differentiating Stress-Enduring Cells Afford Brain Repair in a Mouse Lacunar Stroke Model

被引:41
|
作者
Abe, Takatsugu [1 ]
Aburakawa, Daiki [1 ]
Niizuma, Kuniyasu [1 ,2 ,4 ]
Iwabuchi, Naoya [1 ]
Kajitani, Takumi [1 ]
Wakao, Shohei [3 ]
Kushida, Yoshihiro [3 ]
Dezawa, Mari [3 ]
Borlongan, Cesar V. [5 ]
Tominaga, Teiji [1 ]
机构
[1] Tohoku Univ, Grad Sch Med, Dept Neurosurg, Sendai, Miyagi, Japan
[2] Tohoku Univ, Grad Sch Med, Dept Neurosurg Engn & Translat Neurosci, Sendai, Miyagi, Japan
[3] Tohoku Univ, Grad Sch Med, Dept Stem Cell Biol & Histol, Sendai, Miyagi, Japan
[4] Tohoku Univ, Grad Sch Biomed Engn, Dept Neurosurg Engn & Translat Neurosci, Sendai, Miyagi, Japan
[5] Univ S Florida, Coll Med, Dept Neurosurg & Brain Repair, 12901 Bruce B Downs Blvd, Tampa, FL 33620 USA
基金
日本学术振兴会;
关键词
bone marrow; infarction; mice; mitochondria; stem cells; HUMAN MUSE CELLS; MESENCHYMAL STEM-CELLS; FUNCTIONAL RECOVERY; EMERGING PARADIGM; CEREBRAL-ISCHEMIA; THERAPY; NEUROTRANSPLANTATION; SUBPOPULATION; REPLACEMENT; INFARCTS;
D O I
10.1161/STROKEAHA.119.026589
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-Multilineage-differentiating stress-enduring cells are endogenous nontumorigenic reparative pluripotent-like stem cells found in bone marrow, peripheral blood, and connective tissues. Topically administered human multilineage-differentiating stress-enduring cells into rat/mouse stroke models differentiated into neural cells and promoted clinically relevant functional recovery. However, critical questions on the appropriate timing and dose, and safety of the less invasive intravenous administration of clinical-grade multilineage-differentiating stress-enduring cell-based product CL2020 remain unanswered. Methods-Using an immunodeficient mouse lacunar model, CL2020 was administered via the cervical vein in different doses (high dose=5x10(4) cells/body; medium dose=1x10(4) cells/body; low dose=5x10(3) cells/body) at subacute phase (approximate to 9 days after onset) and chronic phase (approximate to 30 days). Cylinder test, depletion of human cells by diphtheria toxin administration, immunohistochemistry, and human specific-genome detection were performed. Results-Tumorigenesis and adverse effects were not detected for up to 22 weeks. The high-dose group displayed significant functional recovery compared with the vehicle group in cylinder test in subacute-phase-treated and chronic-phase-treated animals after 6 weeks and 8 weeks post-injection, respectively. In the high-dose group of subacute-phase-treated animals, robust and stable recovery in cylinder test persisted up to 22 weeks compared with the vehicle group. In both groups, intraperitoneal injection of diphtheria toxin abrogated the functional recovery. Anti-human mitochondria revealed CL2020 distributed mainly in the peri-infarct area at 1, 10, and 22 weeks and expressed NeuN (neuronal nuclei)- and MAP-2 (microtubule-associated protein-2)-immunoreactivity. Conclusions-Intravenously administered CL2020 was safe, migrated to the peri-infarct area, and afforded functional recovery in experimental stroke. Visual Overview-An online visual overview is available for this article.
引用
收藏
页码:601 / 611
页数:11
相关论文
共 50 条
  • [1] Mobilization of Pluripotent Multilineage-Differentiating Stress-Enduring Cells in Ischemic Stroke
    Hori, Emiko
    Hayakawa, Yumiko
    Hayashi, Tomohide
    Hori, Satoshi
    Okamoto, Soushi
    Shibata, Takashi
    Kubo, Michiya
    Horie, Yukio
    Sasahara, Masakiyo
    Kuroda, Satoshi
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2016, 25 (06): : 1473 - 1481
  • [2] Therapeutic Potential of Multilineage-Differentiating Stress-Enduring Cells for Osteochondral Repair in a Rat Model
    Mahmoud, Elhussein Elbadry
    Kamei, Naosuke
    Shimizu, Ryo
    Wakao, Shohei
    Dezawa, Mari
    Adachi, Nobuo
    Ochi, Mitsuo
    STEM CELLS INTERNATIONAL, 2017, 2017
  • [3] Multilineage-differentiating stress-enduring cells: a powerful tool for tissue damage repair
    Que, Hanyun
    Mai, Erziya
    Hu, Yanting
    Li, Hong
    Zheng, Wenxin
    Jiang, Yuchen
    Han, Feiruo
    Li, Xuedong
    Gong, Puyang
    Gu, Jian
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2024, 12
  • [4] The evaluation of the safety and efficacy of intravenously administered allogeneic multilineage-differentiating stress-enduring cells in a swine hepatectomy model
    Masahiro Iseki
    Masamichi Mizuma
    Shohei Wakao
    Yoshihiro Kushida
    Katsuyoshi Kudo
    Masahiko Fukase
    Masaharu Ishida
    Tomoyuki Ono
    Mitsuhiro Shimura
    Ichiro Ise
    Yukie Suzuki
    Teruko Sueta
    Ryuta Asada
    Shinobu Shimizu
    Yoshiyuki Ueno
    Mari Dezawa
    Michiaki Unno
    Surgery Today, 2021, 51 : 634 - 650
  • [5] The evaluation of the safety and efficacy of intravenously administered allogeneic multilineage-differentiating stress-enduring cells in a swine hepatectomy model
    Iseki, Masahiro
    Mizuma, Masamichi
    Wakao, Shohei
    Kushida, Yoshihiro
    Kudo, Katsuyoshi
    Fukase, Masahiko
    Ishida, Masaharu
    Ono, Tomoyuki
    Shimura, Mitsuhiro
    Ise, Ichiro
    Suzuki, Yukie
    Sueta, Teruko
    Asada, Ryuta
    Shimizu, Shinobu
    Ueno, Yoshiyuki
    Dezawa, Mari
    Unno, Michiaki
    SURGERY TODAY, 2021, 51 (04) : 634 - 650
  • [6] Multilineage-Differentiating Stress-Enduring Cells (Muse Cells): The Future of Human and Veterinary Regenerative Medicine
    Velasco, Maria Gemma
    Satue, Katy
    Chicharro, Deborah
    Martins, Emma
    Torres-Torrillas, Marta
    Pelaez, Pau
    Miguel-Pastor, Laura
    Del Romero, Ayla
    Damia, Elena
    Cuervo, Belen
    Carrillo, Jose Maria
    Cugat, Ramon
    Sopena, Joaquin Jesus
    Rubio, Monica
    BIOMEDICINES, 2023, 11 (02)
  • [7] Isolation, culture and evaluation of multilineage-differentiating stress-enduring (Muse) cells
    Kuroda, Yasumasa
    Wakao, Shohei
    Kitada, Masaaki
    Murakami, Toru
    Nojima, Makoto
    Dezawa, Mari
    NATURE PROTOCOLS, 2013, 8 (07) : 1391 - 1415
  • [8] Intravenously injected human multilineage-differentiating stress-enduring cells selectively engraft into mouse aortic aneurysms and attenuate dilatation by differentiating into multiple cell types
    Hosoyama, Katsuhiro
    Wakao, Shohei
    Kushida, Yoshihiro
    Ogura, Fumitaka
    Maeda, Kay
    Adachi, Osamu
    Kawamoto, Shunsuke
    Dezawa, Mari
    Saiki, Yoshikatsu
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2018, 155 (06): : 2301 - +
  • [9] Isolation, culture and evaluation of multilineage-differentiating stress-enduring (Muse) cells
    Yasumasa Kuroda
    Shohei Wakao
    Masaaki Kitada
    Toru Murakami
    Makoto Nojima
    Mari Dezawa
    Nature Protocols, 2013, 8 : 1391 - 1415
  • [10] Multilineage-differentiating stress-enduring (Muse)-like cells exist in synovial tissue
    Toyoda, Eriko
    Sato, Masato
    Takahashi, Takumi
    Maehara, Miki
    Nakamura, Yoshihiko
    Mitani, Genya
    Takagaki, Tomonori
    Hamahashi, Kosuke
    Watanabe, Masahiko
    REGENERATIVE THERAPY, 2019, 10 : 17 - 26